FDA inspection
Nippon Sanso Matheson, Inc.: FDA inspection ending Apr 20, 2022
FDA inspection 1169352 · No Action Indicated (NAI) · Grimes, IA
Key facts
| Inspection ID | 1169352 |
|---|---|
| Firm | Nippon Sanso Matheson, Inc. |
| FEI number | 3008264101 |
| Address | 1255 Sw Brookside Cir |
| City | Grimes |
| State | IA |
| ZIP | 50111 |
| Country | United States |
| Fiscal year | 2022 |
| Inspection end date | Apr 20, 2022 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data